Los Angeles Capital Management LLC Assembly Biosciences, Inc. Transaction History

Los Angeles Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$3.8 - $4.56 $52,649 - $63,178	-13,855 Closed	0 $0
Q1 2021 May 05, 2021	SELL	$4.33 - $6.63 $62,503 - $95,704	-14,435 Reduced 51.03%	13,855 $63,000
Q4 2020 Feb 04, 2021	BUY	$4.87 - $17.29 $20,794 - $73,828	4,270 Added 17.78%	28,290 $171,000
Q3 2020 Nov 02, 2020	BUY	$15.08 - $27.04 $362,221 - $649,500	24,020 New	24,020 $395,000
Q2 2020 Aug 05, 2020	SELL	$14.57 - $23.96 $190,284 - $312,917	-13,060 Closed	0 $0
Q1 2020 May 04, 2020	BUY	$10.27 - $21.23 $134,126 - $277,263	13,060 New	13,060 $194,000

16.3K

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $723M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Los Angeles Capital Management LLC with notifications on news.